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The Liverpool Epidemic Strain (LES) is a polylysogenic, transmissible strain of Pseudomonas
aeruginosa, capable of superinfecting existing P. aeruginosa respiratory infections in individuals with
cystic fibrosis (CF). The LES phages are highly active in the CF lung and may have a role in the
competitiveness of the LES in vivo. In this study, we tested this by competing isogenic PAO1 strains
that differed only by the presence or absence of LES prophages in a rat model of chronic lung
infection. Lysogens invaded phage-susceptible populations, both in head-to-head competition and
when invading from rare, in the spatially structured, heterogeneous lung environment. Appreciable
densities of free phages in lung tissue confirmed active phage lysis in vivo. Moreover, we observed
lysogenic conversion of the phage-susceptible competitor. These results suggest that temperate
phages may have an important role in the competitiveness of the LES in chronic lung infection by
acting as anti-competitor weapons.
The ISME Journal advance online publication, 12 April 2016; doi:10.1038/ismej.2016.51
The LES is a transmissible strain of Pseudomonas
aeruginosa that causes life-limiting chronic respira-
tory infections in individuals with CF (Fothergill
et al., 2012). Unusually, the LES is capable of
superinfection to displace other strains of P. aerugi-
nosa, even after years of chronic colonisation
(McCallum et al., 2001; Winstanley et al., 2009),
but there is no evidence that it can be displaced by
other strains (Fothergill et al., 2010; Mowat et al.,
2011; Williams et al., 2015). The LES harbours five
prophages, highly active in the CF lung (James et al.,
2015), four of which have been shown by signature-
tagged mutagenesis to be necessary for bacterial
competitiveness in a rat model of chronic lung
infection (Winstanley et al., 2009; Lemieux et al.,
2015). Theoretical and empirical studies suggest that
temperate phages could enhance the competitive-
ness of lysogens by killing phage-susceptible com-
petitors by lysis (Bossi et al., 2003; Brown et al.,
2006; Joo et al., 2006; Burns et al., 2014), a form of
phage-mediated allelopathy (Stewart and Levin,
1984). However, it is unclear whether this ecological
mechanism operates in the far more complex
spatially structured and heterogeneous lung
environment.
To test whether temperate phages increase com-
petitive fitness during lung infection, we performed
competition experiments between lysogenic and
non-lysogenic strains of P. aeruginosa in a rat model
of chronic lung infection (Winstanley et al., 2009).
We constructed antibiotic-resistance-labelled PAO1
LES-Phage Lysogens (PLPLs) (James et al., 2012)
using three of the LES phages (LESϕ2, LESϕ3 and
LESϕ4), both individually and in combination (for
full methods, see Supplementary information).
Initial in vitro experiments suggested that the triple
lysogen (PAO1ϕtriple ) was more invasive than any
of the constituent single lysogens (Supplementary
Figure S1), therefore PAO1ϕtriple was selected for
use in the in vivo experiments. Competitors were
embedded in agar beads in PLPL to PAO1ϕ− ratios of
1:5 or 1:1, to model invasion-from-rare and head-to-
head competition, respectively. Rats were infected
with inoculated agar beads by intubation and
monitored for 7 days, after which they were killed.
The densities of each competitor in the lungs were
quantified (Supplementary Table S2) and the selec-
tion rate constant (rij) was calculated as described
previously (Lenski et al., 1991).
PAO1ϕtriple outcompeted PAO1ϕ− in vivo (Figure 1),
at both initial starting frequencies (competition experi-
ment, 1 sample t-test (alt=0), t6=20.3, Po0.001; invasion
experiment, 1 sample t-test (alt=0), t3=15.8, Po0.01),
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but there was no effect of initial starting frequency on
fitness (2-sample t-test; t6=1.08, P=0.32). Thus, tempe-
rate phages improved the competitiveness and invasive-
ness of lysogens against phage-susceptible populations in
chronic lung infection. To confirm the role of phage lysis,
we also measured levels of free infective phages in the
lung homogenate. We observed appreciable densities of
virions in the lungs in both treatments, with no
significant difference in mean (±1 s.d.) phage-to-
bacterium ratios between the competition (0.55±0.84)
and invasion (0.47±0.44) treatments (2-sample t-test on
log10+1 transformed data; t6=−0.11, P=0.91).
Phage-mediated invasion by lysogens can be
limited by lysogenic conversion of the originally
phage-susceptible competitor, creating phage-
resistant lysogens (Gama et al., 2013). Having found
that lysogenic conversion occurs at a very high
frequency in vitro (Supplementary Figure S2), we
investigated whether the phages also established
lysogeny in vivo. We calculated for each animal the
total lysogen frequency and proportion of each
lysogen type for end point populations by screening
46 bacterial lung isolates of the initially phage-free
competitor (PAO1ϕ− ) using a multiplex PCR assay
(Supplementary Methods and Supplementary
Table S1). We observed appreciable rates of lyso-
genic conversion at both initial starting frequencies,
but with substantial variation between animals
(Figure 2). Although the mean (±1 s.d.) total fre-
quency of lysogens was higher in head-to-head
competition (0.89 ±0.03) compared with invasion-
from-rare (0.56 ± 0.07) treatment (2-sample t-test;
t6 = 8.57, Po0.01) (due to a proportion of the
PLPLϕtriple competitor), the rate of lysogenic con-
version of PAO1ϕ− (Figure 2) was similar in both
treatments (Mann–Whitney U test; W=42.5, n1 = 7,
n2 = 4, P=1.00). Lysogenic conversion of PAO1ϕ−
was dominated by the formation of LESϕ2 and
LESϕ3 lysogens, suggesting that these phages were
most active in the lung, which is consistent with the
high free-phage densities of these phages in human
CF infections (James et al., 2015).
These data provide important experimental evi-
dence supporting the role for phage-mediated allelo-
pathy as a determinant of pathogen fitness in chronic
lung infection. This extends previous studies using
observational (James et al., 2015) and insect model
approaches (Burns et al., 2014) to confirm, in a
clinically relevant environment, that the LES-
temperate phages are likely to have had a key role
in the global spread of the LES. Crucially, we
Figure 1 Selection rate constant for the competition outcome
between PAO1ϕ− and PAO1ϕtriple at different starting ratios of
competitors. Each data point represents the outcome of competi-
tion in the lungs of an individual animal after 7 days, with the
exception of the two circled data points. These represent two rats
that were killed after 2 days, as they were showing symptoms of
acute infection, with high bacterial loads (100-fold higher than
other lungs after 7 days). These were excluded from statistical
analyses.
Figure 2 Lysogenic conversion of PAO1ϕ− after 7 days in vivo. Prophage complement of streptomycin-labelled bacteria (initially
PAO1ϕ− ) isolated from rat lungs in (a) head-to-head competition and (b) invasion-from-rare treatments. Height of bars denote the
frequency of the competitor out of total bacteria. Data are reported separately for each animal.
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demonstrate that phage-mediated allelopathy allows
lysogens to invade from rare, even in the complex,
spatially structured, heterogeneous host lung envir-
onment, which has previously been theoretically
predicted, but has never been demonstrated (Gama
et al., 2013). In agreement with a recent observa-
tional clinical study of the ecological dynamics of
the LES and its phages in CF patient sputa, we show
the production of appreciable populations of free-
phage virions by lysis in the lung (James et al., 2015).
We observed lysogenic conversion in the lung, but at
rates lower than those observed in liquid in vitro
environments (Supplementary Figure S2), suggesting
that lysogenic conversion may have been impeded in
the lung environment. Consistent with this, recent
evidence suggests that bacterial populations show
strong regional structure within the CF lung, with
low rates of mixing between regions of the lung (Jorth
et al., 2015). Nevertheless, the transfer of genetic
material among strains of P. aeruginosa within infec-
tions does raise concerns about the potential for the
horizontal gene transfer of antibiotic resistance or
virulence determinants (Penadés et al., 2015).
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